HIGHLIGHTS
- who: Retno Ningsi and colleagues from the Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany have published the Article: Detection and Characterization of Estrogen Receptor Expression of Circulating Tumor Cells as a Prognostic Marker, in the Journal: Cancers 2022, 14, 2621. https:// of 30/03/2022
- what: The authors evaluated the ER-CTC status using the ERu03b1 monoclonal murine ER-119.3 antibody, which to the knowledge , has been tested only once so far. The authors aimed to reproduce the previously published staining conditions in_vitro, followed by testing a cohort of metastatic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.